| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 08/19/1997 | US5658565 Encoding of protein by nucleic acid transferred to cells in vascular occlusion site; drug delivery |
| 08/14/1997 | WO1997029213A1 Coding sequences of the human brca1 gene |
| 08/14/1997 | WO1997029202A1 Vectors and methods for providing cells with additional nucleic acid material integrated in the genome of said cells |
| 08/14/1997 | WO1997029201A2 Retroviral vector for the gene transfer of an il6 antagonist in human haematopoietic stem cells |
| 08/14/1997 | WO1997029196A1 Variants of thymidine kinase, related nucleic acids sequences and their use in genic therapy |
| 08/14/1997 | WO1997029195A2 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same |
| 08/14/1997 | WO1997029189A1 Human neuronal attachment factor-1 |
| 08/14/1997 | WO1997029183A2 Methods and compositions for transforming dendritic cells and activating t cells |
| 08/14/1997 | WO1997029180A1 Diabetes therapy |
| 08/14/1997 | WO1997029119A1 Fhit proteins and nucleic acids and methods based thereon |
| 08/14/1997 | WO1997029113A2 Process for preparing purified nucleic acid and the use thereof |
| 08/14/1997 | WO1997028818A1 Novel methods of vaccination and vaccines therefore comprising a nucleic acid encoding a first epitope and a peptide containing a second epitope |
| 08/14/1997 | WO1997028817A1 Receptor ligand-facilitated delivery of biologically active molecules |
| 08/14/1997 | DE19704979A1 Retroviral vector for expressing interleukin-6 antagonist in human haematopoietic stem cells |
| 08/14/1997 | DE19605105A1 Neue Sonde zur Früherkennung von epithelialen Dysplasien des mehrschichtigen Plattenepithels sowie zur Tumordiagnostik und Tumortherapie von Plattenepithelkarzinomen New probe for early detection of epithelial dysplasia of the stratified squamous epithelium as well as for tumor diagnosis and tumor therapy of squamous cell carcinoma |
| 08/14/1997 | CA2733866A1 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same |
| 08/14/1997 | CA2245783A1 Fhit proteins and nucleic acids and methods based thereon |
| 08/14/1997 | CA2245508A1 Variants of thymidine kinase, related nucleic acids sequences and their use in genic therapy |
| 08/14/1997 | CA2245170A1 Methods and compositions for transforming dendritic cells and activating t cells |
| 08/14/1997 | CA2244812A1 Vectors and methods for providing cells with additional nucleic acid material integrated in the genome of said cells |
| 08/14/1997 | CA2244110A1 Novel methods of vaccination and vaccines thereof comprising a nucleic acid encoding a first epitope and a peptide containing a second epitope |
| 08/14/1997 | CA2243718A1 Diabetes therapy |
| 08/13/1997 | EP0789077A1 Viral material and nucleotide fragments associated with multiple sclerose having diagnostic, prophylactic and therapeutical uses |
| 08/13/1997 | EP0789076A2 G protein coupled receptor proteins, their production and use |
| 08/13/1997 | EP0788543A1 Alk-7 (activin like kinase), a serine threonine kinase receptor |
| 08/13/1997 | EP0788540A1 Human abh |
| 08/13/1997 | EP0788374A2 Cell-specific gene delivery vehicles |
| 08/13/1997 | EP0788367A1 Stretch-activated cation channel and antisense oligonucleotides thereto |
| 08/13/1997 | EP0788366A1 Use of 2'-substituted oligonucleotides to down-regulating gene expression |
| 08/13/1997 | EP0788364A1 Treatment of urogenital cancer with boron neutron capture therapy |
| 08/13/1997 | EP0788307A1 Oligonucleotide modulation of multidrug resistance-associated protein |
| 08/13/1997 | CN1156966A Polynucleotide vaccine for papillomavirus |
| 08/13/1997 | CA2197408A1 Mutant human growth hormones and their uses |
| 08/13/1997 | CA2197286A1 Nucleic acid constructs for the cell cycle-regulated expression of genes, cells containing such constructs and their use for preparing drugs |
| 08/13/1997 | CA2197265A1 Target cell-specific vectors for inserting genes into cells, pharmaceuticals comprising such vectors and their use |
| 08/12/1997 | US5656612 Antisense oligonucleotide modulation of raf gene expression |
| 08/12/1997 | US5656611 Modified polynucleotide and copolymer having polyether segments and polycation segments; stabilizing polynucleic acids and increasing ability to cross cell membranes |
| 08/12/1997 | US5656610 Injection into tongue muscle |
| 08/12/1997 | US5656609 Method of enhancing and/or prolonging expression of gene introduced into a cell using colchicine |
| 08/12/1997 | US5656481 Compositions and methods for the delivery of biologically active molecules using cells contained in biocompatible capsules |
| 08/12/1997 | US5656465 Methods of in vivo gene delivery |
| 08/12/1997 | US5656267 Implantable cells that alleviate chronic pain in humans |
| 08/07/1997 | WO1997028269A1 Transduced human hematopoietic stem cells |
| 08/07/1997 | WO1997028266A1 Human dnase resistant to actin inhibition |
| 08/07/1997 | WO1997028265A1 Measles immunization by dna transcription unit inoculation |
| 08/07/1997 | WO1997028259A1 Gene expression vectors which generate an antigen specific immune response and methods of using the same |
| 08/07/1997 | WO1997028258A1 Cells expressing both human cd4 and cxcr4 |
| 08/07/1997 | WO1997028251A1 Combined radiotherapy and immunotherapy to treat cancer |
| 08/07/1997 | WO1997028191A1 Mhc complexes and uses thereof |
| 08/07/1997 | WO1997028186A1 PURIFIED SR-p70 PROTEIN |
| 08/07/1997 | WO1997028178A1 High affinity nucleic acid ligands of complement system proteins |
| 08/07/1997 | WO1997028175A1 Thyroid sodium/iodide symporter and nucleic acid encoding same |
| 08/07/1997 | WO1997027876A1 Immunotherapy sensitization of cancer therapy |
| 08/07/1997 | WO1997027871A1 Method of inactivation of ras subfamily proteins and agents therefor |
| 08/07/1997 | WO1997021811A3 Novel tyrosine kinase receptors and ligands |
| 08/07/1997 | WO1997012985A3 Multi-functional hematopoietic receptor agonists |
| 08/07/1997 | DE19603668A1 Increasing immune response to tumour cells by increasing expression of TAP or LMP proteins |
| 08/07/1997 | CA2630098A1 High affinity nucleic acid ligands of complement system proteins |
| 08/07/1997 | CA2244841A1 Combined radiotherapy and immunotherapy to treat cancer |
| 08/07/1997 | CA2244755A1 Mhc complexes and uses thereof |
| 08/07/1997 | CA2196964A1 G protein coupled receptor proteins, their production and use |
| 08/06/1997 | EP0787799A1 Staphylococcus aureus WCUH29 SpoIIIE Protein |
| 08/06/1997 | EP0787797A1 Human 5-HT1D receptor (serotonin receptor), process for preparing the same, its uses, antibodies directed against this receptor and transgenics expressing it |
| 08/06/1997 | EP0787206A1 USE OF NEURITE LOCALIZED mRNAs FOR MEDICAL DIAGNOSIS AND THERAPEUTICS |
| 08/06/1997 | EP0787201A1 Poly(organo)phosphazenes for use in synthetic transfection systems |
| 08/06/1997 | EP0787200A2 Improved adenovirus and methods of use thereof |
| 08/06/1997 | EP0787199A1 Viable contaminant particle free adenoviruses, their preparation and use |
| 08/06/1997 | EP0787198A1 Defective adenoviruses including a therapeutic gene and an immunoprotective gene |
| 08/06/1997 | EP0787197A1 Immortalized lines of endothelial brain cells and therapeutical applications thereof |
| 08/06/1997 | EP0787190A2 Hepatitis e virus antigens and uses therefor |
| 08/06/1997 | EP0787182A2 Embryonal cardiac muscle cells, their preparation and their use |
| 08/06/1997 | EP0787145A1 Novel tnf receptor death domain ligand proteins and inhibitors of ligand binding |
| 08/06/1997 | EP0787142A1 Neurturin and related growth factors |
| 08/06/1997 | EP0787016A1 Secretory leukocyte protease inhibitor as an inhibitor of tryptase |
| 08/06/1997 | EP0787012A1 Suppression of proteolytic activity by dysfunctional protease formation |
| 08/06/1997 | EP0786989A1 Lipid vesicles containing adeno-associated virus rep protein for transgene integration and gene therapy |
| 08/06/1997 | EP0585368B1 Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products |
| 08/05/1997 | US5654415 Antisense oligonucleotides to p53 |
| 08/05/1997 | US5654185 Methods, compositions and apparatus for cell transfection |
| 08/05/1997 | US5654182 Site-specific integration or disassembly of nucleic acid sequences within the genome of a mammilian host cell for the activation or inactivation of a functional expression unit; lineage analysis of tissues |
| 08/05/1997 | US5654155 Diagnosis of breast or ovanian cancer |
| 08/05/1997 | US5654007 Friable, spherically aggregated particles of powdered drug; free-flowing, respiratory inhalants |
| 08/05/1997 | US5653975 Implanting encapsulated cells capable of producing human growth factor or trophic factor for diffusion into the central nervous system; treatment of diabetes; anemia; hypoparathyroidism; parkinson's and alzheimer's disease |
| 08/05/1997 | CA1339205C Oligonucleotide-polyamide conjugates |
| 07/31/1997 | WO1997027310A1 Retroviral vector and its use in gene therapy |
| 07/31/1997 | WO1997027301A1 Decorin binding protein compositions and methods of use |
| 07/31/1997 | WO1997027300A1 TOXOPLASMA GONDII ANTIGEN Tg20 |
| 07/31/1997 | WO1997027297A1 Inhibitors of cell-cycle progression, and uses related thereto |
| 07/31/1997 | WO1997027296A1 Nucleic acids and proteins related to alzheimer's disease, and uses therefor |
| 07/31/1997 | WO1997027286A1 Methods for using the obese gene and its gene product to stimulate hematopoietic development |
| 07/31/1997 | WO1997027284A2 Human rad50 and septin-2 genes and methods of use |
| 07/31/1997 | WO1997027216A1 Amplification of response from expressed recombinant protein |
| 07/31/1997 | WO1997027208A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 07/31/1997 | WO1997027206A1 Oligonucleotide analogs |
| 07/31/1997 | WO1997026910A2 Tumour vaccine for immunotherapy of malignant tumours |
| 07/31/1997 | WO1997026903A1 Microencapsulated genetically engineered microorganisms for clinical application |
| 07/31/1997 | WO1997026853A2 Dna encoding galanin galr2 receptors and uses thereof |
| 07/31/1997 | WO1997026790A1 APOPTOSIS INDUCED BY SHIGELLA IpaB |
| 07/31/1997 | DE19602985A1 Tumour vaccine for treatment of, e.g., carcinoma melanoma or leukaemia |
| 07/31/1997 | DE19602863A1 Agent for treating cancer and other diseases involving hyper-proliferation of cells |